1. Academic Validation
  2. Postmarketing pharmacovigilance: Remdesivir and cardiovascular events

Postmarketing pharmacovigilance: Remdesivir and cardiovascular events

  • Clin Transl Sci. 2022 Apr;15(4):813-815. doi: 10.1111/cts.13261.
John T Sullivan 1
Affiliations

Affiliation

  • 1 Retired.
Figures
Products